OTR3
Paris
About OTR3
OTR3 is a biotechnology company founded by Professors Denis Barritault and Jean-Pierre Caruelle† from the University of Paris-East Créteil in 2000, laureates of the French national competition for the creation of the best innovative company. Known for their pioneering work on growth factors – the discovery of FGF, HARP/PTN – they invented the RGTA® Technology (ReGeneraTing Agents), a new therapeutic class in regenerative medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.9M
- Last round: Grant (Oct 2018)
- Website: otr3.com
- Phone: +33 (0)1 83 64 23 00
Industries & Categories
Biotechnology, Cosmetics, Medical Device, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/otr3-23733 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.